Phase 2A

Phase 2A. Means the Phase 2A or Phase 1/2 clinical trials, as prescribed by the FDA and agencies of other governments of other countries having similar jurisdiction over the development, manufacturing and marketing of pharmaceuticals, designed to evaluate efficacy and initial clinical proof of concept.